HZNP News and Press, Horizon Therapeutics Public Limited Company From 05/24/22

John Paulson’s 13F portfolio value increased marginally from $3.24B to $3.25B this quarter. Paulson & Company added SPDR Gold Trust ETF while reducing Pacira BioSciences and TIM S.A. They also dropped Shell plc and TotalEnergies SE. The top three positions are at 43% of...

-- Oral presentation on KRYSTEXXA ® (pegloticase injection) plus methotrexate to be held June 2, 2022 at 11:35 a.m. CEST-- -- Additional data presentations provide new insights on psychosocial and comorbidity impact of gout to help inform evolving treatment strate...

John Paulson's fund, Paulson & Co. reported its 13F filing for Q2 wherein it added Agnico Eagle Mines (AEM) and SPDR Gold Trust ETF (GLD) in new positions It increased its stakes in Bausch Health (BHC), Horizon Therapeutics (HZNP), BrightSphere Investment (BSIG), NovaGold Resources (NG), ...

Horizon Therapeutics plc (Nasdaq: HZNP) today announced the first patient has enrolled in a Phase 2, open-label, proof-of-concept trial to evaluate its development-stage medicine daxdilimab (HZN-7734), a potentially first-in-class, fully human monoclonal antibody targeting immunoglobuli...

Among patient groups familiar with Horizon, the company ranked first in patient group relationships, integrity, services beyond the pill and patient centricity Horizon Therapeutics plc (Nasdaq: HZNP) today announced that it ranked second in overall corporate reputation among...

Horizon Therapeutics plc (Nasdaq: HZNP) today announced that Dara Mann, vice president, marketing, ophthalmology, has been named a 2022 Healthcare Businesswomen’s Association (HBA) Rising Star. Mann was honored at the 2022 HBA Woman of the Year event yesterday. The HBA is the...

-- Nationwide campaign spotlights mental health impact of living with TED -- For Mental Health Awareness Month and Healthy Vision Month in May, Horizon Therapeutics plc (Nasdaq: HZNP) is partnering with mental health expert and New York Times best-selling author, Lori Go...

- Partnership Makes Horizon the Official and Exclusive Biotech Partner of the Chicago Sky and Includes Community Programming - Horizon Therapeutics (Nasdaq: HZNP) and the Chicago Sky today announced a multi-year partnership, which includes robust community programming as wel...

Horizon's inflammation segment is on fire in a not good way. The biopharmaceutical firm's orphan therapies segment presents another, far more interesting opportunity. The company is performing well in a perilous market environment. For further details see: Horizon: For T...

Horizon Therapeutics Public Limited Company (HZNP) Q1 2022 Earnings Conference Call May 04, 2022 08:00 AM ET Company Participants Tina Ventura - Senior Vice President, Chief Investor Relations Officer Tim Walbert - Chairman, President & Chief Executive Officer Liz Thompson - Executive Vic...